What’s Next For Clovis Oncology?

Clovis Oncology has delivered big results in a much-waited late-stage clinical trial for its ovarian cancer drug. Is a takeover on the horizon?
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.